Compugen Ltd. won the required Shareholder approval for every proposal presented at its 2026 Annual General Meeting on September 10, 2026. Investors now have a clear governance outcome from the meeting, with the full agenda receiving the requisite majority and related meeting materials having been submitted on August 3.

Key Highlights

  • Compugen held its 2026 annual general meeting on September 10, 2026.
  • Meeting materials were submitted to the Securities and Exchange Commission on August 3, 2026.
  • Eran Ben Dor signed on behalf of Compugen as general counsel.

Compugen Ltd. (NASDAQ: CGEN) received the required shareholder backing for every proposal presented at its 2026 annual general meeting on September 10, 2026. Each item cleared the voting threshold specified for the meeting, leaving all proposals approved.

Every Proposal Clears the Shareholder Vote

The meeting followed the earlier submission of its notice, proxy statement and proxy card to the Securities and Exchange Commission on August 3, 2026. Those materials related to the agenda presented to shareholders at the annual meeting. Compugen identifies its principal executive offices at 26 Harokmim Street, Holon 5,885,849, Israel. Eran Ben Dor, the company’s general counsel, signed the report on Compugen’s behalf.

Full Meeting Agenda Receives Required Majority

The approval covered every proposal brought before shareholders, rather than only selected items. For investors, the central outcome is a completed shareholder vote in which the full meeting agenda received the requisite majority.